 | • レポートコード：QYR9NV01726 • 出版社/出版日：QYResearch / 2019年11月12日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥525,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,050,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、生体タンパク質薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、モノクローナル抗体、治療用タンパク質、ワクチンに、用途別には、製薬およびバイオテクノロジー企業、CRO、アカデミックにセグメント区分し、生体タンパク質薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・生体タンパク質薬の世界市場概要 ・生体タンパク質薬の製造コスト構成分析 ・生体タンパク質薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・生体タンパク質薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・生体タンパク質薬のセグメント分析（種類別） （モノクローナル抗体、治療用タンパク質、ワクチン） ・生体タンパク質薬のセグメント分析（用途別） （製薬およびバイオテクノロジー企業、CRO、アカデミック） ・生体タンパク質薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Abbott Laboratories、Bayer AG、Eli Lilly and Company、Amgen Inc.、Biocon Ltd.、Dr. Reddy’s Laboratories、Roche、Fresenius kabi、GlaxoSmithKline、Johnson & Johnson、Merck、Novartis AG、Panacea Biotec、ProBioGen AG、Sanofi、Reliance Life Science Pvt. Ltd.、） ・生体タンパク質薬の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Bio-protein Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Bio-protein Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bio-protein Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Bio-protein Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Bio-protein Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Abbott Laboratories
Bayer AG
Eli Lilly and Company
Amgen Inc.
Biocon Ltd.
Dr. Reddy’s Laboratories
Roche
Fresenius kabi
GlaxoSmithKline
Johnson & Johnson
Merck
Novartis AG
Panacea Biotec
ProBioGen AG
Sanofi
Reliance Life Science Pvt. Ltd.
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Monoclonal Antibodies
Therapeutic Proteins
Vaccines
Segment by Application
Pharma and Biotech Companies
CROs
Academics
Table of Contents
Executive Summary
1 Industry Overview of Bio-protein Drug
1.1 Definition of Bio-protein Drug
1.2 Bio-protein Drug Segment by Type
1.2.1 Global Bio-protein Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Monoclonal Antibodies
1.2.3 Therapeutic Proteins
1.2.4 Vaccines
1.3 Bio-protein Drug Segment by Applications
1.3.1 Global Bio-protein Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Pharma and Biotech Companies
1.3.3 CROs
1.3.4 Academics
1.4 Global Bio-protein Drug Overall Market
1.4.1 Global Bio-protein Drug Revenue (2014-2025)
1.4.2 Global Bio-protein Drug Production (2014-2025)
1.4.3 North America Bio-protein Drug Status and Prospect (2014-2025)
1.4.4 Europe Bio-protein Drug Status and Prospect (2014-2025)
1.4.5 China Bio-protein Drug Status and Prospect (2014-2025)
1.4.6 Japan Bio-protein Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Bio-protein Drug Status and Prospect (2014-2025)
1.4.8 India Bio-protein Drug Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Bio-protein Drug
2.3 Manufacturing Process Analysis of Bio-protein Drug
2.4 Industry Chain Structure of Bio-protein Drug
3 Development and Manufacturing Plants Analysis of Bio-protein Drug
3.1 Capacity and Commercial Production Date
3.2 Global Bio-protein Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Bio-protein Drug
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Bio-protein Drug Production and Capacity Analysis
4.2 Bio-protein Drug Revenue Analysis
4.3 Bio-protein Drug Price Analysis
4.4 Market Concentration Degree
5 Bio-protein Drug Regional Market Analysis
5.1 Bio-protein Drug Production by Regions
5.1.1 Global Bio-protein Drug Production by Regions
5.1.2 Global Bio-protein Drug Revenue by Regions
5.2 Bio-protein Drug Consumption by Regions
5.3 North America Bio-protein Drug Market Analysis
5.3.1 North America Bio-protein Drug Production
5.3.2 North America Bio-protein Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Bio-protein Drug Import and Export
5.4 Europe Bio-protein Drug Market Analysis
5.4.1 Europe Bio-protein Drug Production
5.4.2 Europe Bio-protein Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Bio-protein Drug Import and Export
5.5 China Bio-protein Drug Market Analysis
5.5.1 China Bio-protein Drug Production
5.5.2 China Bio-protein Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Bio-protein Drug Import and Export
5.6 Japan Bio-protein Drug Market Analysis
5.6.1 Japan Bio-protein Drug Production
5.6.2 Japan Bio-protein Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Bio-protein Drug Import and Export
5.7 Southeast Asia Bio-protein Drug Market Analysis
5.7.1 Southeast Asia Bio-protein Drug Production
5.7.2 Southeast Asia Bio-protein Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Bio-protein Drug Import and Export
5.8 India Bio-protein Drug Market Analysis
5.8.1 India Bio-protein Drug Production
5.8.2 India Bio-protein Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Bio-protein Drug Import and Export
6 Bio-protein Drug Segment Market Analysis (by Type)
6.1 Global Bio-protein Drug Production by Type
6.2 Global Bio-protein Drug Revenue by Type
6.3 Bio-protein Drug Price by Type
7 Bio-protein Drug Segment Market Analysis (by Application)
7.1 Global Bio-protein Drug Consumption by Application
7.2 Global Bio-protein Drug Consumption Market Share by Application (2014-2019)
8 Bio-protein Drug Major Manufacturers Analysis
8.1 Abbott Laboratories
8.1.1 Abbott Laboratories Bio-protein Drug Production Sites and Area Served
8.1.2 Abbott Laboratories Product Introduction, Application and Specification
8.1.3 Abbott Laboratories Bio-protein Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bayer AG
8.2.1 Bayer AG Bio-protein Drug Production Sites and Area Served
8.2.2 Bayer AG Product Introduction, Application and Specification
8.2.3 Bayer AG Bio-protein Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Eli Lilly and Company
8.3.1 Eli Lilly and Company Bio-protein Drug Production Sites and Area Served
8.3.2 Eli Lilly and Company Product Introduction, Application and Specification
8.3.3 Eli Lilly and Company Bio-protein Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Amgen Inc.
8.4.1 Amgen Inc. Bio-protein Drug Production Sites and Area Served
8.4.2 Amgen Inc. Product Introduction, Application and Specification
8.4.3 Amgen Inc. Bio-protein Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Biocon Ltd.
8.5.1 Biocon Ltd. Bio-protein Drug Production Sites and Area Served
8.5.2 Biocon Ltd. Product Introduction, Application and Specification
8.5.3 Biocon Ltd. Bio-protein Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Dr. Reddy’s Laboratories
8.6.1 Dr. Reddy’s Laboratories Bio-protein Drug Production Sites and Area Served
8.6.2 Dr. Reddy’s Laboratories Product Introduction, Application and Specification
8.6.3 Dr. Reddy’s Laboratories Bio-protein Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Roche
8.7.1 Roche Bio-protein Drug Production Sites and Area Served
8.7.2 Roche Product Introduction, Application and Specification
8.7.3 Roche Bio-protein Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Fresenius kabi
8.8.1 Fresenius kabi Bio-protein Drug Production Sites and Area Served
8.8.2 Fresenius kabi Product Introduction, Application and Specification
8.8.3 Fresenius kabi Bio-protein Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 GlaxoSmithKline
8.9.1 GlaxoSmithKline Bio-protein Drug Production Sites and Area Served
8.9.2 GlaxoSmithKline Product Introduction, Application and Specification
8.9.3 GlaxoSmithKline Bio-protein Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Johnson & Johnson
8.10.1 Johnson & Johnson Bio-protein Drug Production Sites and Area Served
8.10.2 Johnson & Johnson Product Introduction, Application and Specification
8.10.3 Johnson & Johnson Bio-protein Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Merck
8.12 Novartis AG
8.13 Panacea Biotec
8.14 ProBioGen AG
8.15 Sanofi
8.16 Reliance Life Science Pvt. Ltd.
9 Development Trend of Analysis of Bio-protein Drug Market
9.1 Global Bio-protein Drug Market Trend Analysis
9.1.1 Global Bio-protein Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Bio-protein Drug Regional Market Trend
9.2.1 North America Bio-protein Drug Forecast 2019-2025
9.2.2 Europe Bio-protein Drug Forecast 2019-2025
9.2.3 China Bio-protein Drug Forecast 2019-2025
9.2.4 Japan Bio-protein Drug Forecast 2019-2025
9.2.5 Southeast Asia Bio-protein Drug Forecast 2019-2025
9.2.6 India Bio-protein Drug Forecast 2019-2025
9.3 Bio-protein Drug Market Trend (Product Type)
9.4 Bio-protein Drug Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Bio-protein Drug Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Bio-protein Drug
Table Global Bio-protein Drug Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Bio-protein Drug Production Market Share by Types in 2018
Figure Monoclonal Antibodies Product Picture
Figure Therapeutic Proteins Product Picture
Figure Vaccines Product Picture
Table Global Bio-protein Drug Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Bio-protein Drug Consumption Market Share by Applications in 2018
Figure Pharma and Biotech Companies
Figure CROs
Figure Academics
Figure Global Bio-protein Drug Revenue (Million USD) (2014-2025)
Figure Global Bio-protein Drug Production (K Units) (2014-2025)
Figure North America Bio-protein Drug Market Size (Million USD) (2014-2025)
Figure Europe Bio-protein Drug Market Size (Million USD) (2014-2025)
Figure China Bio-protein Drug Market Size (Million USD) (2014-2025)
Figure Japan Bio-protein Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Bio-protein Drug Market Size (Million USD) (2014-2025)
Figure India Bio-protein Drug Market Size (Million USD) (2014-2025)
Table Bio-protein Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Bio-protein Drug in 2018
Figure Manufacturing Process Analysis of Bio-protein Drug
Figure Industry Chain Structure of Bio-protein Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Bio-protein Drug Manufacturing Plants Distribution
Table Bio-protein Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Bio-protein Drug Capacity (K Units) of Major Manufacturers (2014-2019)
Table Bio-protein Drug Production (K Units) of Major Manufacturers (2014-2019)
Table Bio-protein Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Bio-protein Drug Production Share by Manufacturers in 2018
Table Bio-protein Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Bio-protein Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Bio-protein Drug Revenue Share by Manufacturers in 2018
Table Bio-protein Drug Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Bio-protein Drug Production by Regions 2014-2019 (K Units)
Table Global Bio-protein Drug Production Market Share by Regions 2014-2019
Figure Global Bio-protein Drug Production Market Share by Regions in 2018
Table Global Bio-protein Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Bio-protein Drug Revenue Market Share by Regions 2014-2019
Figure Global Bio-protein Drug Revenue Market Share by Regions in 2018
Table Global Bio-protein Drug Consumption by Regions 2014-2019 (K Units)
Table Global Bio-protein Drug Consumption Market Share by Regions 2014-2019
Figure North America Bio-protein Drug Production Growth Rate 2014-2019 (K Units)
Figure North America Bio-protein Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Bio-protein Drug Production, Consumption Import and Export (K Units)
Figure Europe Bio-protein Drug Production Growth Rate 2014-2019 (K Units)
Figure Europe Bio-protein Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Bio-protein Drug Production, Consumption Import and Export (K Units)
Figure China Bio-protein Drug Production Growth Rate 2014-2019 (K Units)
Figure China Bio-protein Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Bio-protein Drug Production, Consumption Import and Export (K Units)
Figure Japan Bio-protein Drug Production Growth Rate 2014-2019 (K Units)
Figure Japan Bio-protein Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Bio-protein Drug Production, Consumption Import and Export (K Units)
Figure Southeast Asia Bio-protein Drug Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Bio-protein Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Bio-protein Drug Production, Consumption Import and Export (K Units)
Figure India Bio-protein Drug Production Growth Rate 2014-2019 (K Units)
Figure India Bio-protein Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Bio-protein Drug Production, Consumption Import and Export (K Units)
Figure Global Consumption Bio-protein Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Bio-protein Drug Market Share by Application (2014-2019)
Table Abbott Laboratories Bio-protein Drug Production Sites and Area Served
Table Abbott Laboratories Bio-protein Drug Product Introduction, Application and Specification
Table Abbott Laboratories Bio-protein Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Laboratories Bio-protein Drug Production Growth Rate (2014-2019)
Table Abbott Laboratories Bio-protein Drug Production Market Share (2014-2019)
Figure Abbott Laboratories Bio-protein Drug Revenue Market Share (2014-2019)
Table Abbott Laboratories Bio-protein Drug Main Business and Markets Served
Table Bayer AG Bio-protein Drug Production Sites and Area Served
Table Bayer AG Bio-protein Drug Product Introduction, Application and Specification
Table Bayer AG Bio-protein Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer AG Bio-protein Drug Production Growth Rate (2014-2019)
Table Bayer AG Bio-protein Drug Production Market Share (2014-2019)
Figure Bayer AG Bio-protein Drug Revenue Market Share (2014-2019)
Table Bayer AG Bio-protein Drug Main Business and Markets Served
Table Eli Lilly and Company Bio-protein Drug Production Sites and Area Served
Table Eli Lilly and Company Bio-protein Drug Product Introduction, Application and Specification
Table Eli Lilly and Company Bio-protein Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly and Company Bio-protein Drug Production Growth Rate (2014-2019)
Table Eli Lilly and Company Bio-protein Drug Production Market Share (2014-2019)
Figure Eli Lilly and Company Bio-protein Drug Revenue Market Share (2014-2019)
Table Eli Lilly and Company Bio-protein Drug Main Business and Markets Served
Table Amgen Inc. Bio-protein Drug Production Sites and Area Served
Table Amgen Inc. Bio-protein Drug Product Introduction, Application and Specification
Table Amgen Inc. Bio-protein Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Inc. Bio-protein Drug Production Growth Rate (2014-2019)
Table Amgen Inc. Bio-protein Drug Production Market Share (2014-2019)
Figure Amgen Inc. Bio-protein Drug Revenue Market Share (2014-2019)
Table Amgen Inc. Bio-protein Drug Main Business and Markets Served
Table Biocon Ltd. Bio-protein Drug Production Sites and Area Served
Table Biocon Ltd. Bio-protein Drug Product Introduction, Application and Specification
Table Biocon Ltd. Bio-protein Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Biocon Ltd. Bio-protein Drug Production Growth Rate (2014-2019)
Table Biocon Ltd. Bio-protein Drug Production Market Share (2014-2019)
Figure Biocon Ltd. Bio-protein Drug Revenue Market Share (2014-2019)
Table Biocon Ltd. Bio-protein Drug Main Business and Markets Served
Table Dr. Reddy’s Laboratories Bio-protein Drug Production Sites and Area Served
Table Dr. Reddy’s Laboratories Bio-protein Drug Product Introduction, Application and Specification
Table Dr. Reddy’s Laboratories Bio-protein Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Dr. Reddy’s Laboratories Bio-protein Drug Production Growth Rate (2014-2019)
Table Dr. Reddy’s Laboratories Bio-protein Drug Production Market Share (2014-2019)
Figure Dr. Reddy’s Laboratories Bio-protein Drug Revenue Market Share (2014-2019)
Table Dr. Reddy’s Laboratories Bio-protein Drug Main Business and Markets Served
Table Roche Bio-protein Drug Production Sites and Area Served
Table Roche Bio-protein Drug Product Introduction, Application and Specification
Table Roche Bio-protein Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Bio-protein Drug Production Growth Rate (2014-2019)
Table Roche Bio-protein Drug Production Market Share (2014-2019)
Figure Roche Bio-protein Drug Revenue Market Share (2014-2019)
Table Roche Bio-protein Drug Main Business and Markets Served
Table Fresenius kabi Bio-protein Drug Production Sites and Area Served
Table Fresenius kabi Bio-protein Drug Product Introduction, Application and Specification
Table Fresenius kabi Bio-protein Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Fresenius kabi Bio-protein Drug Production Growth Rate (2014-2019)
Table Fresenius kabi Bio-protein Drug Production Market Share (2014-2019)
Figure Fresenius kabi Bio-protein Drug Revenue Market Share (2014-2019)
Table Fresenius kabi Bio-protein Drug Main Business and Markets Served
Table GlaxoSmithKline Bio-protein Drug Production Sites and Area Served
Table GlaxoSmithKline Bio-protein Drug Product Introduction, Application and Specification
Table GlaxoSmithKline Bio-protein Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Bio-protein Drug Production Growth Rate (2014-2019)
Table GlaxoSmithKline Bio-protein Drug Production Market Share (2014-2019)
Figure GlaxoSmithKline Bio-protein Drug Revenue Market Share (2014-2019)
Table GlaxoSmithKline Bio-protein Drug Main Business and Markets Served
Table Johnson & Johnson Bio-protein Drug Production Sites and Area Served
Table Johnson & Johnson Bio-protein Drug Product Introduction, Application and Specification
Table Johnson & Johnson Bio-protein Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Bio-protein Drug Production Growth Rate (2014-2019)
Table Johnson & Johnson Bio-protein Drug Production Market Share (2014-2019)
Figure Johnson & Johnson Bio-protein Drug Revenue Market Share (2014-2019)
Table Johnson & Johnson Bio-protein Drug Main Business and Markets Served
Table Merck Bio-protein Drug Production Sites and Area Served
Table Novartis AG Bio-protein Drug Production Sites and Area Served
Table Panacea Biotec Bio-protein Drug Production Sites and Area Served
Table ProBioGen AG Bio-protein Drug Production Sites and Area Served
Table Sanofi Bio-protein Drug Production Sites and Area Served
Table Reliance Life Science Pvt. Ltd. Bio-protein Drug Production Sites and Area Served
Figure Global Bio-protein Drug Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Bio-protein Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Bio-protein Drug Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Bio-protein Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Bio-protein Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Bio-protein Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Bio-protein Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Bio-protein Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Bio-protein Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Bio-protein Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Bio-protein Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Bio-protein Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Bio-protein Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Bio-protein Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Bio-protein Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Bio-protein Drug by Type (2019-2025)
Table Global Consumption (K Units) of Bio-protein Drug by Application (2019-2025)
Table Bio-protein Drug Distributors List
Table Bio-protein Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
バイオエンジニアリングタンパク質医薬品の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Scope of the Report: This report focuses on the Bioengineered Protein Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Bioengineered proteins …- 新薬液送達システムの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. …
- がんワクチン薬物パイプラインの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. Scope of the Report: This report studies the Cancer Vaccines Drug Pipeline market status and outlook of Global and major regions, from angles of players, countries…
- プロテインAクロマトグラフィー樹脂のグローバル市場調査 2019年 The global Protein A Chromatography Resin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Protein A Chromatography Resin volume and value at global level, regional level and company level. From a gl…
- プロテインキナーゼ阻害剤のグローバル市場調査 2019年 The global Protein Kinase Inhibitor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Protein Kinase Inhibitor volume and value at global level, regional level and company level. From a global perspec…